FDA’s approach to regulatory strategy

May 2023: United States


Reagan-Udall Foundation evaluation of FDA’s tobacco program – a response

24 public health experts respond to the Reagan-Udall Foundation evaluation of FDA’s Center for Tobacco Products and its policymaking and practice. RUF suggests that there is a void where there should be a strategy. We suggest a strategic framework with four main pillars and four supporting actions. The response is discussed in greater detail at this blog: Rethinking U.S. tobacco and nicotine regulation (part 2)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Scroll to Top